| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
|
Saleheen, Danish
|
|
2017
|
5 |
7 |
p. 524-533
|
artikel
|
| 2 |
Artificial pancreas research: you can observe a lot by watching
|
Russell, Steven J
|
|
2017
|
5 |
7 |
p. 484-485
|
artikel
|
| 3 |
Concepts in diagnosis and therapy for male reproductive impairment
|
Tournaye, Herman
|
|
2017
|
5 |
7 |
p. 554-564
|
artikel
|
| 4 |
Critical fat studies and obesity in Canada
|
Sharma, Arya M
|
|
2017
|
5 |
7 |
p. 499-500
|
artikel
|
| 5 |
Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
|
Weisman, Alanna
|
|
2017
|
5 |
7 |
p. 501-512
|
artikel
|
| 6 |
Exercise and physical activity in patients with type 1 diabetes
|
Campbell, Matthew D
|
|
2017
|
5 |
7 |
p. 493
|
artikel
|
| 7 |
Exercise and physical activity in patients with type 1 diabetes – Authors' reply
|
Riddell, Michael C
|
|
2017
|
5 |
7 |
p. 493-494
|
artikel
|
| 8 |
Lipoprotein(a) and cardiovascular mortality: mystery still unsolved
|
Santos, Raul D
|
|
2017
|
5 |
7 |
p. 489-490
|
artikel
|
| 9 |
Neuroendocrine tumours emerge from the shadows
|
Gilbert, Judith A
|
|
2017
|
5 |
7 |
p. 498
|
artikel
|
| 10 |
Novel concepts in the aetiology of male reproductive impairment
|
Tournaye, Herman
|
|
2017
|
5 |
7 |
p. 544-553
|
artikel
|
| 11 |
PCSK9 inhibitors: smooth sailing or a little turbulence ahead?
|
Hegele, Robert A
|
|
2017
|
5 |
7 |
p. 490-492
|
artikel
|
| 12 |
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study
|
Zewinger, Stephen
|
|
2017
|
5 |
7 |
p. 534-543
|
artikel
|
| 13 |
Research digest: topical trials in thyroid disease
|
Preiss, David
|
|
2017
|
5 |
7 |
p. 497
|
artikel
|
| 14 |
Sacubitril/valsartan in PARADIGM-HF
|
Guglin, Maya
|
|
2017
|
5 |
7 |
p. 494-495
|
artikel
|
| 15 |
Sacubitril/valsartan in PARADIGM-HF
|
Flores, Dayana
|
|
2017
|
5 |
7 |
p. 495
|
artikel
|
| 16 |
Sacubitril/valsartan in PARADIGM-HF
|
Vodovar, Nicolas
|
|
2017
|
5 |
7 |
p. 495-496
|
artikel
|
| 17 |
Sacubitril/valsartan in PARADIGM-HF – Authors' reply
|
Seferovic, Jelena P
|
|
2017
|
5 |
7 |
p. 496
|
artikel
|
| 18 |
Safety of long-term denosumab therapy for osteoporosis
|
Compston, Juliet
|
|
2017
|
5 |
7 |
p. 485-487
|
artikel
|
| 19 |
Should we officially recognise obesity as a disease?
|
The Lancet Diabetes & Endocrinology,
|
|
2017
|
5 |
7 |
p. 483
|
artikel
|
| 20 |
What role for lipoprotein(a) in clinical practice?
|
Nicholls, Stephen J
|
|
2017
|
5 |
7 |
p. 487-489
|
artikel
|
| 21 |
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
|
Bone, Henry G
|
|
2017
|
5 |
7 |
p. 513-523
|
artikel
|
Tijdschrift beschrijving